Posted by Michael Wonder on 27 Aug 2020
Drug makers to sue government for limiting choline alfoscerate benefit
27 August 2020 - Manufacturers of choline alfoscerate, a dementia drug, are reportedly preparing to file an administrative lawsuit against the government for limiting the national health insurance benefit for the medication from September.
The Ministry of Health and Welfare on Wednesday put a public notice about details on the renewed standards and methods of applying insurance benefits to choline alfoscerate drugs, following the reassessment of the drug’s reimbursement.
